Most lately, it's been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds into a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger and won't activate a 2n